Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

311.72
-4.3600-1.38%
Post-market: 312.290.5680+0.18%19:57 EDT
Volume:193.65K
Turnover:60.70M
Market Cap:18.76B
PE:33.84
High:316.68
Open:315.93
Low:311.37
Close:316.08
52wk High:330.75
52wk Low:260.42
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.10
T/O Rate:0.32%
Dividend:4.61
Dividend Rate:1.48%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.95
PE(LYR):7.51

Loading ...

InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development

Reuters
·
Yesterday

Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division

Reuters
·
Yesterday

Lilly Says Foundayo Cuts Predicted 10-Year Type 2 Diabetes Risk 57% in Attain-1 Post-Hoc Analysis

Reuters
·
Yesterday

Eli Lilly - Foundayo 17.2 Mg Associated with 57% Reduction in Diabetes Risk, 18% in Cardiovascular Risk Versus Placebo

Reuters
·
Yesterday

Eli Lilly - Foundayo Associated with Reduced Predicted Long-Term Risk of Type 2 Diabetes and Cardiovascular Disease

THOMSON REUTERS
·
Yesterday

UnitedHealth - 95% of Medicare-Eligible Individuals to Have Access to Hmo Plan in 2027

THOMSON REUTERS
·
Yesterday

Unitedhealthcare 2027 Medicare Plans Focus on Affordability, Simplicity and a More Connected Healthcare Experience

THOMSON REUTERS
·
Yesterday

Unitedhealthcare: 2027 Plans Offer $0 Primary Care Visits, $0 Preventive Care, $0 Tier 1 Drug Copays

THOMSON REUTERS
·
Yesterday

Unitedhealthcare: Introduces 2027 Medicare Advantage Plans; About 90% of Eligible Consumers to Have Access to $0 Premium

THOMSON REUTERS
·
Yesterday

UnitedHealthcare, Aetna Say 2027 Medicare Advantage Plans to Offer More Limited Provider Networks

Reuters
·
Yesterday

Merck Schedules Third-Quarter Sales and Earnings Conference Call with Investors and Analysts

Reuters
·
Yesterday

Johnson & Johnson (JNJ) Stock Could Be Undervalued On Future Cash Flow

Simply Wall St.
·
Yesterday

Merck & Co Inc : Jefferies Raises Target Price to $177 from $175

THOMSON REUTERS
·
Yesterday

RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Yesterday

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
Yesterday

Nexsen reshapes leadership to drive growth in point-of-care diagnostics

TIPRANKS
·
Yesterday

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
Yesterday

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
Yesterday

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
Yesterday

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
Yesterday